Telstar will lead the launch of a new business called Life Science Engineering
Japanese corporation Azbil has taken an 80% stake in Telstar, the Spanish supplier of equipment for the life sciences.
Ton Capella, Telstar’s executive president, will retain the remaining 20% stake. He will continue as managing director and remain a director of the board.
Tokyo-headquartered Azbil is a measurement and control technologies company focused on ‘human-centred automation’, which contributes to people’s safety, comfort and fulfilment and covers building automation, plant and factory automation and life automation in healthcare.
Telstar says the move will enable it to expand its business in the life sciences to provide ‘next-generation solutions which integrate manufacturing equipment with environmental systems, inspired by automation technologies’ to markets that contribute to people’s health.
The move will enable Telstar to expand its business in the life sciences
As part of Azbil, Telstar will lead the launch of a new business called Life Science Engineering, which will combine Telstar’s design, engineering and manufacturing process knowledge and Azbil’s automation technologies to provide new solutions that enhance safety and productivity in the workplace. It will develop business globally in expanding markets, such as biopharmaceuticals, life science research, personalised medicine, regenerative medicine, and functional foods, and is aiming to achieve sales in excess of €200m within five years.
The two companies have technological and operating synergies and complementary geographic sales networks, Telstar says.
Through this partnership, Azbil will strengthen its overseas sales operations by using Telstar’s sales network in the pharmaceutical, laboratory, and hospital sectors in Europe, Latin America, and North America, while Telstar will expand into Asia, as well as apply Azbil’s technologies to new product development and system integration.